Health Care & Life Sciences » Pharmaceuticals | Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,786
4,888
8,027
5,230
12,616
Total Accounts Receivable
29,633
40,268
50,790
38,454
43,179
Inventories
23,675
36,113
40,561
43,305
58,584
Other Current Assets
1,217
1,719
3,566
5,072
7,499
Total Current Assets
56,312
82,988
102,944
92,062
121,878
Net Property, Plant & Equipment
28,497
33,574
43,345
54,219
62,089
Total Investments and Advances
4,228
19
1,262
2,552
3,267
Long-Term Note Receivable
2,751
2,975
327
809
910
Intangible Assets
2,246
8,531
8,115
9,715
19,676
Other Assets
864
1,011
1,147
1,460
1,643
Total Assets
94,898
129,145
159,202
162,494
211,052
ST Debt & Current Portion LT Debt
24,898
30,896
42,983
31,827
43,187
Accounts Payable
13,512
20,511
24,570
21,547
26,274
Income Tax Payable
459
1,446
820
265
431
Other Current Liabilities
3,331
8,511
10,029
12,417
16,913
Total Current Liabilities
42,200
61,364
78,402
66,056
86,806
Long-Term Debt
12,794
13,615
7,428
1,814
4,512
Provision for Risks & Charges
92
244
234
391
559
Deferred Taxes
2,054
2,058
1,823
1,185
765
Total Liabilities
57,140
77,328
86,304
68,754
94,230
Common Equity (Total)
37,502
51,559
72,873
93,719
116,804
Total Shareholders' Equity
37,502
51,559
72,873
93,719
116,804
Total Equity
37,758
51,817
72,899
93,740
116,822
Liabilities & Shareholders' Equity
94,898
129,145
159,202
162,494
211,052
Accumulated Minority Interest
257
258
26
21
18

About Aurobindo Pharma

View Profile
Address
Water Mark Building
Hyderabad TS 500084
India
Employees -
Website http://www.aurobindo.com
Updated 09/14/2018
Aurobindo Pharma Ltd. engages in the manufacture of generic pharmaceuticals and active pharmaceutical ingredients. It operates through the following geographical segments: India, USA, Europe, and Rest of the World. It portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics.